| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |